GNH USA

Europe — EMA

Nanospect (Human Serum Albumin)

GNH USA supplies Nanospect (Human Serum Albumin), a plasma expander for volume replacement in hypoalbuminemia, burns and surgery.

Request sourcing

1
Pack/s

What is Human Serum Albumin?

Human Serum Albumin, the active ingredient in Nanospect, is a plasma expander presented as a sterile solution for intravenous use. It increases plasma oncotic pressure, helping to expand intravascular volume in patients with low albumin levels or acute fluid loss.\n\nGNH India supplies Nanospect as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide.

What is Human Serum Albumin used for?

Human Serum Albumin is used as a plasma volume expander in several clinical situations.\n\n- Hypoalbuminemia: restores oncotic pressure and supports circulatory stability.\n- Major burns: provides fluid resuscitation and maintains vascular volume.\n- Surgical blood loss: helps replace lost plasma proteins and sustain intravascular volume.\n- Liver disease with ascites: reduces edema by increasing plasma oncotic pressure.

What are the side effects of Human Serum Albumin?

Human Serum Albumin may be associated with several adverse reactions.\n\nCommon Side Effects:\n- Fever or chills during infusion.\n- Mild rash or urticaria at the infusion site.\n- Transient hypotension or hypertension.\n- Headache or dizziness.\n- Nausea or mild gastrointestinal discomfort.\n\nSerious or Rare Side Effects:\n- Anaphylactic or severe allergic reaction.\n- Acute pulmonary edema due to fluid overload.\n- Hemolysis or renal impairment in susceptible patients.\n- Thromboembolic events related to increased blood viscosity.\n- Transmission of infectious agents (extremely rare with modern manufacturing).

What precautions apply to Human Serum Albumin?

Human Serum Albumin should be administered with careful clinical monitoring.\n\n- Allergy assessment: verify no known hypersensitivity to albumin products.\n- Volume status: monitor for signs of fluid overload, especially in cardiac or renal disease.\n- Renal function: evaluate kidney performance before and during therapy.\n- Infection risk: maintain strict aseptic technique during preparation and infusion.\n- Compatibility: confirm compatibility with other intravenous solutions before mixing.\n- Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Serum Albumin interact with?

Human Serum Albumin may interact with certain medications and solutions.\n\nMajor Interactions (Avoid):\n- Co-administration with high-dose diuretics: risk of severe hypovolemia.\n- Incompatible IV admixtures: precipitation or loss of efficacy.\n\nModerate Interactions (Monitor Closely):\n- ACE inhibitors: monitor blood pressure and renal function.\n- Beta‑blockers: observe cardiovascular response during volume expansion.\n- Other plasma expanders or colloids: assess cumulative volume load and oncotic effects.

Frequently asked questions

What is Nanospect used for?+
Nanospect is a sterile human serum albumin solution used as a plasma volume expander. It helps restore oncotic pressure and intravascular volume in conditions such as hypoalbuminemia, severe burns, major surgery, and certain liver diseases where fluid balance is compromised.
How does human serum albumin work in the body?+
Human serum albumin increases plasma oncotic pressure, which draws water from the interstitial space into the bloodstream. This osmotic shift expands circulating blood volume, improves tissue perfusion, and supports hemodynamic stability while also serving as a carrier for various endogenous and exogenous substances.
What is the usual dose of Nanospect?+
The dose of Nanospect is individualized and determined by the prescribing clinician based on the patient’s clinical condition, albumin level, and fluid requirements. Dosage calculations consider factors such as body weight, severity of hypoalbuminemia, and the volume of fluid loss.
Is Nanospect safe during pregnancy or breastfeeding?+
Human serum albumin is classified as a Category C product for pregnancy, meaning it should only be used if the potential benefit justifies the potential risk to the fetus. Limited data are available for breastfeeding, so clinicians should weigh the benefits against possible risks before administration.
How do I order Nanospect from GNH USA?+
To order Nanospect, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.
How does Nanospect compare with other plasma expanders?+
Nanospect (human serum albumin) is a natural protein‑based colloid, offering oncotic pressure similar to native plasma. Compared with synthetic colloids such as hydroxyethyl starch, albumin has a lower risk of coagulopathy and renal impairment, but it is generally more expensive and requires cold‑chain storage.
What are the storage and handling requirements for Nanospect?+
Nanospect must be stored at 2‑8 °C, protected from light, and kept in its original container. It should not be frozen or shaken vigorously. Before use, inspect the solution for particulate matter or discoloration and allow it to reach room temperature if required for infusion.
How is Nanospect administered?+
Nanospect is administered intravenously, typically as an infusion. The rate and volume are determined by the prescriber, who may start with a slow infusion to assess tolerance and then adjust based on the patient’s response and clinical goals.
What are the most serious risks associated with Nanospect?+
Serious risks include anaphylactic reactions, severe fluid overload leading to pulmonary edema, and rare transmission of infectious agents. Patients with known albumin hypersensitivity, severe cardiac or renal dysfunction, or uncontrolled hypertension require close monitoring during administration.
Who should not receive Nanospect?+
Nanospect should be avoided in individuals with a documented allergy to human serum albumin, in patients with uncontrolled congestive heart failure or severe renal impairment where fluid overload is a concern, and in those receiving incompatible intravenous solutions without proper assessment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Human Serum Albumin
Route
Intravenous Use , Subcutaneous Use
Manufacturer
Rotop Pharmaka Gmbh
Origin
EU

Related products